My research focuses primarily on the evaluation of neurovascular disease using Magnetic Resonance Imaging (MRI). I research the development of Magnetic Resonance Imaging to diagnose and evaluate diseases that affect the vasculature and the underlying physiology. My focus has been primarily to neurovascular disease and stroke. However, given the system nature of vascular disease my work has a more broad appeal. Many of the conditions which precipitate neurovascular disease, such as atherosclerosis, have a common underpinning.
University of Wisconsin
Madison, WI
- Medical Imaging
2002
Max-Planck Institute
Munich, Germany
Fellowship - High Energy Physics
1997
University of Illinois-Chicago
Chicago, IL
PhD - High Energy Physics
1994
University of Illinois
Urbana, IL
BS - Physics
1985
Identifying features of prior hemorrhage in cerebral cavernous malformations on quantitative susceptibility maps: a machine learning pilot study.
Identifying features of prior hemorrhage in cerebral cavernous malformations on quantitative susceptibility maps: a machine learning pilot study. J Neurosurg. 2025 Dec 01; 143(6):1567-1574.
PMID: 40614265
A Method for Imaging the Ischemic Penumbra with MRI Using Intravoxel Incoherent Motion.
A Method for Imaging the Ischemic Penumbra with MRI Using Intravoxel Incoherent Motion. AJNR Am J Neuroradiol. 2025 Jul 01; 46(7):1336-1344.
PMID: 39805668
A Review of Intracranial Aneurysm Imaging Modalities, from CT to State-of-the-Art MR.
A Review of Intracranial Aneurysm Imaging Modalities, from CT to State-of-the-Art MR. AJNR Am J Neuroradiol. 2025 Jun 03; 46(6):1082-1092.
PMID: 39443148
Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis.
Validation of retroactively derived T1 relaxation values from 3D T1-weighted images with clinical and MRI measures of disability in multiple sclerosis. PLoS One. 2025; 20(5):e0323898.
PMID: 40388456
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial.
Safety and efficacy of atorvastatin for rebleeding in cerebral cavernous malformations (AT CASH EPOC): a phase 1/2a, randomised placebo-controlled trial. Lancet Neurol. 2025 Apr; 24(4):295-304.
PMID: 40120614
BrainXcan identifies brain features associated with behavioral and psychiatric traits using large-scale genetic and imaging data.
BrainXcan identifies brain features associated with behavioral and psychiatric traits using large-scale genetic and imaging data. Dev Cogn Neurosci. 2025 Jun; 73:101542.
PMID: 40101670
Acute Intermittent Hypoxia in People Living With Chronic Stroke: A Case Series.
Acute Intermittent Hypoxia in People Living With Chronic Stroke: A Case Series. Stroke. 2025 Apr; 56(4):1054-1057.
PMID: 39996325
Quantification of Collateral Supply with Local-AIF Dynamic Susceptibility Contrast MRI Predicts Infarct Growth.
Quantification of Collateral Supply with Local-AIF Dynamic Susceptibility Contrast MRI Predicts Infarct Growth. AJNR Am J Neuroradiol. 2025 Feb 03; 46(2):251-258.
PMID: 39134367
Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformations.
Circulating molecules reflect imaging biomarkers of hemorrhage in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2025 Jun; 45(6):1153-1165.
PMID: 39829356
An in-silico investigation of the effect of changing cycling crank power and cadence on muscle energetics and active muscle volume.
An in-silico investigation of the effect of changing cycling crank power and cadence on muscle energetics and active muscle volume. J Biomech. 2025 Feb; 180:112530.
PMID: 39837154